Ignite Creation Date:
2024-05-06 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03552029
Status:
TERMINATED
Last Update Posted:
2022-05-20
First Post:
2018-05-17
Brief Title:
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia AML
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-17
First Submit QC Date:
May 29 2018
Study First Post Date:
2018-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-05-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-14
Last Update Post Date:
2022-05-20
Last Update Post Date Type:
ACTUAL